

Olema Pharmaceuticals shares fall after completing OPERA-01 Phase 3 enrollment, with top-line data now expected in Q1 2027.
You can purchase shares of Olema Pharmaceuticals (NASDAQ:OLMA) through any online brokerage.
Other companies in Olema Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Olema Pharmaceuticals has a consensus price target of $40.67.
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $7.36 last updated November 9, 2026 at 4:00 PM EST.
There are no upcoming dividends for Olema Pharmaceuticals.
Olema Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Olema Pharmaceuticals.
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve...